Serum Concentration of CRIPTO‐1 in Pregnancies Complicated by Placenta Accreta Spectrum
BioMed Research International · 2026-01 · 2026 (1)
DOI: 10.1155/bmri/2476601 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioMed Research International, online erschienen am 09.07.2026. Verfasst von Livia Alves Lopes und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil, usp.br. Hauptthemen laut MEDLINE: GPI-Linked Proteins, Placenta Accreta, Intercellular Signaling Peptides and Proteins, Placenta Previa. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade de São Paulo.
Abstract (Originalsprache)
Objective
To compare maternal serum CRIPTO‐1 concentrations in pregnancies complicated by placenta accreta spectrum (PAS) with those complicated by placenta previa (PP).
Methods
We conducted a prospective, cross‐sectional, comparative study at a tertiary center in São Paulo, Brazil (August 2022–May 2025). Singleton pregnancies with ultrasound‐confirmed PP were included and classified as either PP without accreta or PAS (accreta/increta/percreta) according to standardized imaging criteria and, when applicable, surgical/histopathological confirmation. Maternal venous blood was collected predelivery, and serum CRIPTO‐1 concentrations were measured using ELISA (Human CRIPTO SimpleStep ELISA Kit, Abcam). Primary analyses used nonparametric tests for continuous variables and Fisher′s exact test for categorical variables. The study was approved by the Research Ethics Committee of the University of São Paulo (CAAE 58202122.8.0000.0065; CAAE 55121422.3.0000.0068).
Results
Forty‐three participants were analyzed (PP = 18; PAS = 25). Median serum CRIPTO‐1 did not differ significantly between groups (PP: 0.013 pg/mL, IQR: 0.001–0.067 vs. PAS: 0.079 pg/mL, IQR: 0.005–0.360; p = 0.156). PAS was associated with greater blood loss (median 2240 vs. 568 mL; p < 0.001), higher transfusion rate (88.0% vs. 16.7%; p < 0.001), more ICU admissions (68.0% vs. 16.7%; p = 0.002), longer ICU and hospital stays (both p < 0.01), and higher hysterectomy rates (84.0% vs. 5.6%; p < 0.001).
Conclusions
Predelivery serum CRIPTO‐1 did not discriminate PAS from PP, possibly reflecting physiological variability at delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil, usp.br.
- Instituto de Ciências Biomédicas, University of São Paulo, São Paulo, Brazil, usp.br.
ORCID-Profile: Livia Alves Lopes, Mario Macoto Kondo, Estela Bevilacqua, Carolina Burgarelli Testa, Mario Henrique Burlacchini de Carvalho, Rossana Pulcineli Vieira Francisco, Fábio Roberto Cabar
Förderung
- Universidade de São Paulo
Zitieren
APA
Lopes, L. A., Kondo, M. M., Bevilacqua, E., Testa, C. B., de Carvalho, M. H. B., Francisco, R. P. V., & Cabar, F. R. (2026). Serum Concentration of CRIPTO‐1 in Pregnancies Complicated by Placenta Accreta Spectrum. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/2476601
Vancouver
Lopes LA, Kondo MM, Bevilacqua E, Testa CB, de Carvalho MHB, Francisco RPV, et al. Serum Concentration of CRIPTO‐1 in Pregnancies Complicated by Placenta Accreta Spectrum. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/2476601
BibTeX
@article{Lopes2026,
author = {Lopes, Livia Alves and Kondo, Mario Macoto and Bevilacqua, Estela and Testa, Carolina Burgarelli and de Carvalho, Mario Henrique Burlacchini and Francisco, Rossana Pulcineli Vieira and Cabar, Fábio Roberto},
title = {Serum Concentration of CRIPTO‐1 in Pregnancies Complicated by Placenta Accreta Spectrum},
journal = {BioMed Research International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/bmri/2476601}
}
EUVIMED